Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline Prophylaxis for OHSS in IVF
NCT01535859Phase 3Completed
- Sponsor
- KK Women's and Children's Hospital
- Start
- Apr 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cabergoline in ovarian hyperstimulation syndrome (OHSS), sponsored by KK Women's and Children's Hospital. Started Apr 2012; status: completed.
02
Drugs
cabergoline
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT01535859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535859.